ArticleCancer gene therapy2010

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.

C-K Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.